Methods for evaluating the level of biological aging
JP7874857B2Active Publication Date: 2026-06-17NIPPON MENARD COSMETIC CO
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- NIPPON MENARD COSMETIC CO
- Filing Date
- 2022-05-25
- Publication Date
- 2026-06-17
AI Technical Summary
Technical Problem
Existing methods for evaluating biological aging lack objective and accurate indicators that can correlate with the aging process, particularly in assessing brain function, blood aging, and anti-fatigue ability.
Method used
Using the expression levels of Fractalkine, IL-1α, and TNF-α proteins in biological samples such as saliva or blood as indicators to evaluate biological aging, which are correlated with age-related declines in brain function, blood aging, and anti-fatigue ability.
Benefits of technology
Provides an objective and accurate assessment of biological aging, minimizing subject burden through the use of non-invasive samples like saliva or blood, enabling personalized anti-aging interventions and lifestyle adjustments.
✦ Generated by Eureka AI based on patent content.
Smart Images
Figure 0007874857000004 
Figure 0007874857000005 
Figure 0007874857000006
Abstract
To provide a biological aging level assessment method using an indicator that enables objective and accurate assessment of the biological aging level.SOLUTION: A biological aging level assessment method and an assessment kit are provided, the method using the expression level of one or more proteins selected from Fractalkine, IL-1α, TNF-α, and CD30L in a biological sample as an indicator.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art